PD-L1 protein expression on tumor cells of Epstein-Barr virus- (EBV)-negative DLBCL is detected in 11%-16% of cases and is consistently higher in the non-GCB subtype of DLBCL [37–39]. This evidence concerns the gene CD274 and diffuse large B-cell lymphoma.